First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 1 / Phase 2	2026-09-14		NCT07815678

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics	1

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials